Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil SR 23 mg in Japanese Subjects With Severe Alzheimer's Disease
NCT01276353Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2011
- Primary completion
- Apr 2012
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Jan 2011; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01276353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276353.